OpenVSafe by OpenVAERS
Search V-safe

NT4-11436-83784

2 vaccinations 3 coded responses 18 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
303 / GA
Registered
2021-03-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-20
    Registered in v-safe
  2. 2021-03-20
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-20
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood pressure increased — Feeling: Good
    Free text: Elevated blood pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  12. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-04-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-13
    Survey response — 3 months, dose 2
    MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor
    Free text: Common cold - congestion and runny nose, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-10-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-04-15
    Survey response — 12 months, dose 2
    MedDRA: Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair
    Free text: Mild cold symptoms; runny nose, sore throat
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Pfizer-BioNTech
22021-04-13Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-25

Systemic reaction (other): Elevated blood pressure

Release 9 — 3 months, dose 2

2021-07-13

Symptoms: Common cold - congestion and runny nose, sore throat

Release 11 — 12 months, dose 2

2022-04-15

Symptoms: Mild cold symptoms; runny nose, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SROBlood pressure increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…